FR2309211A1 - Suspension de cefazoline pour administration parenterale - Google Patents

Suspension de cefazoline pour administration parenterale

Info

Publication number
FR2309211A1
FR2309211A1 FR7612617A FR7612617A FR2309211A1 FR 2309211 A1 FR2309211 A1 FR 2309211A1 FR 7612617 A FR7612617 A FR 7612617A FR 7612617 A FR7612617 A FR 7612617A FR 2309211 A1 FR2309211 A1 FR 2309211A1
Authority
FR
France
Prior art keywords
cefazoline
suspension
parenteral administration
parenteral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7612617A
Other languages
English (en)
French (fr)
Other versions
FR2309211B1 (https=
Inventor
Michael Bornstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2309211A1 publication Critical patent/FR2309211A1/fr
Application granted granted Critical
Publication of FR2309211B1 publication Critical patent/FR2309211B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7612617A 1975-04-28 1976-04-28 Suspension de cefazoline pour administration parenterale Granted FR2309211A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/573,283 US4029782A (en) 1975-04-28 1975-04-28 Cefazolin suspension for parenteral administration

Publications (2)

Publication Number Publication Date
FR2309211A1 true FR2309211A1 (fr) 1976-11-26
FR2309211B1 FR2309211B1 (https=) 1979-03-23

Family

ID=24291351

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7612617A Granted FR2309211A1 (fr) 1975-04-28 1976-04-28 Suspension de cefazoline pour administration parenterale

Country Status (8)

Country Link
US (1) US4029782A (https=)
JP (1) JPS51130522A (https=)
AU (1) AU505940B2 (https=)
BE (1) BE841157A (https=)
DE (1) DE2618422A1 (https=)
FR (1) FR2309211A1 (https=)
GB (1) GB1546479A (https=)
ZA (1) ZA761476B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2560043A1 (fr) * 1983-08-19 1985-08-30 May & Baker Ltd Nouvelles compositions injectables a base (d'hydroxy-2 ethyl-)-1 nitro-5 imidazole

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
US6660049B1 (en) 1996-07-31 2003-12-09 Natural Soda Aala, Inc. Process for control of crystallization of inorganics from aqueous solutions
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
RU2310450C2 (ru) * 2002-10-25 2007-11-20 Пфайзер Продактс Инк. Новые депо-препараты для инъекций

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2026740A1 (de) * 1969-06-02 1970-12-10 Merck & Co. Inc., Rahway, N.J. (V.St.A.) Arzneimittelzubereitung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297692A (en) * 1961-04-03 1967-01-10 Lilly Co Eli 7-alkylmercaptoacetamidocephalosporanic acid
GB1051746A (https=) * 1961-12-22
US3293133A (en) * 1963-04-24 1966-12-20 Squibb & Sons Inc Method of imparting color to pharmaceutical solutions
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
GB1244501A (en) * 1968-03-09 1971-09-02 Aspro Nicholas Ltd Heterocyclic amines
US3897423A (en) * 1973-03-05 1975-07-29 Squibb & Sons Inc Amino substituted acylthio cephalosporins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2026740A1 (de) * 1969-06-02 1970-12-10 Merck & Co. Inc., Rahway, N.J. (V.St.A.) Arzneimittelzubereitung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ORGANISH-CHEMISCHE ARZNEIMITTEL UND IHRE SYNONYMA, VOLUME 1, AKADEMIE VERLAG BERLIN, 1971, M. NEGWER *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2560043A1 (fr) * 1983-08-19 1985-08-30 May & Baker Ltd Nouvelles compositions injectables a base (d'hydroxy-2 ethyl-)-1 nitro-5 imidazole

Also Published As

Publication number Publication date
ZA761476B (en) 1977-10-26
BE841157A (fr) 1976-10-27
AU1186876A (en) 1977-09-15
DE2618422A1 (de) 1976-11-11
FR2309211B1 (https=) 1979-03-23
JPS51130522A (en) 1976-11-12
GB1546479A (en) 1979-05-23
US4029782A (en) 1977-06-14
AU505940B2 (en) 1979-12-06

Similar Documents

Publication Publication Date Title
SE7606037L (sv) Anordning for kontinuerlig framstellning av bruk
RO70246A (ro) Procedeu pentru prepararea derivatilor de (1-fenil-2-triazoliletil)-eter
JPS5283331A (en) Nnthiolcarbonyl derivatives of nnphosphonomethylglycin
JPS51123813A (en) Production of cephalosporin for nonnaural administration
SE7610206L (sv) Flasklada av konstemne
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
FR2318635A1 (fr) Derives olefiniques de phenylpiperazines
SE7607677L (sv) Forbettring av lodbarhet
BR7608383A (pt) Conexao desmontavel de cubohaste
FR2309211A1 (fr) Suspension de cefazoline pour administration parenterale
BE841770A (fr) Preparation de 2-aryl-2h-benzotriazoles
FR2335163A1 (fr) Appareillage pour la production de capes de cigares
JPS51128937A (en) Diastereomer of phenylaminoethanol derivatives
SE430615B (sv) Bad for stromlos utfellning av koppar
TR19245A (tr) 3-fenoksibenzaldehidlerin imali
JPS51125379A (en) Production of aminopyrole derivatives
SE7609317L (sv) Bad for fornickling
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
NO143314C (no) Fremgangsmaate for fremstilling av akrylamid
JPS5277083A (en) Nnacyl derivatives of thienamycine
JPS51138668A (en) Production of 211hydroxyy 166pregnenn200one derivatives
JPS5264484A (en) Production of arachidonic aczd
FR2323694A1 (fr) Preparation de 3-methoxymethylcephalosporines
JPS5212186A (en) Production of mydecamycine derivatives
JPS5264483A (en) Production of arachidonic aczd

Legal Events

Date Code Title Description
ST Notification of lapse